The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for ...

Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle ...

The device is designed to lower blood pressure while simultaneously modulating the autonomic nervous system by delivering ...

Despite the positive results, there are open questions about LBB pacing, including long-term lead performance. RCTs are ...

Hospitals are aligning purchasing strategies accordingly. In Q1 and Q2 of 2024, biventricular pacemaker market leaders like Medtronic, Abbott, and Boston Scientific released AI-powered CRT devices ...

The human pacemaker Tara the miniature schnauzer received was donated to the canine by medical device company Medtronic Kelli Bender is the Pets Editor at PEOPLE. She has been working at PEOPLE ...

Another algorithm, available in Medtronic, Guidant, and Biotronik devices, initiates biventricular pacing on top of a ventricular-sensed event, and may allow resynchronization, assuming that ...

Medtronic (MDT) received U.S. Food and Drug Administration approval for the OmniaSecure defibrillation lead for placement within the right ...

Christensen, Clayton M. "We've Got Rhythm! Medtronic Corp.'s Cardiac Pacemaker Business (TN)." Harvard Business School Teaching Note 698-056, March 1998.